Literature DB >> 25892983

A SPECIAL MEETING REVIEW EDITIONAdvances in Hepatic Encephalopathy From EASL 2014: A Review of Selected Presentations From the 49th Annual Meeting of the European Association for the Study of the LiverApril 9-13, 2014 • London, United KingdomWith Expert Commentary by: Steven L. Flamm, MDProfessor of Medicine and SurgeryDivision of Gastroenterology and HepatologyChief of the Liver Transplantation ProgranNorthwestern University Feinberg School of MedicineChicago, Illinois.

.   

Abstract

Entities:  

Year:  2014        PMID： 25892983      PMCID： PMC4222201     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  8 in total

1.  Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2010-06-27       Impact factor: 25.083

2.  Rifaximin treatment in hepatic encephalopathy.

Authors:  Nathan M Bass; Kevin D Mullen; Arun Sanyal; Fred Poordad; Guy Neff; Carroll B Leevy; Samuel Sigal; Muhammad Y Sheikh; Kimberly Beavers; Todd Frederick; Lewis Teperman; Donald Hillebrand; Shirley Huang; Kunal Merchant; Audrey Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

Review 3.  Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations.

Authors:  María Ortiz; Carlos Jacas; Juan Córdoba
Journal:  J Hepatol       Date:  2004-12-28       Impact factor: 25.083

4.  Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations.

Authors:  Jasmohan S Bajaj; Muhammad Hafeezullah; Raymond G Hoffmann; Kia Saeian
Journal:  Am J Gastroenterol       Date:  2007-07-19       Impact factor: 10.864

Review 5.  Current concepts in the assessment and treatment of hepatic encephalopathy.

Authors:  W J Cash; P McConville; E McDermott; P A McCormick; M E Callender; N I McDougall
Journal:  QJM       Date:  2009-11-10

6.  Current concepts in the pathophysiology and management of hepatic encephalopathy.

Authors:  R Todd Frederick
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

7.  The sickness impact profile: validation of a health status measure.

Authors:  M Bergner; R A Bobbitt; W E Pollard; D P Martin; B S Gilson
Journal:  Med Care       Date:  1976-01       Impact factor: 2.983

8.  Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.

Authors:  Manish Kumar Lunia; Barjesh Chander Sharma; Praveen Sharma; Sanjeev Sachdeva; Siddharth Srivastava
Journal:  Clin Gastroenterol Hepatol       Date:  2013-11-15       Impact factor: 11.382
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.